$LIFE

GV 2019 GP, L.L.C. sold $1.4M of LIFE (indirect holdings)

GV 2019 GP, L.L.C. sold 72,482 indirectly-held shares of Ethos Technologies Inc. (LIFE) at an average of $19.17 ($19.05–$19.72, $1.39M total) across 3 trades over 2026-07-21 to 2026-07-22.

Original reporting
SEC EDGAR · GV 2019 GP, L.L.C.
Published Jul 23, 2026, 8:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 8:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LIFE
Neutral
medium confidence
Mentioned
$LIFE
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFENeutralLow
01

Why it matters

The newest disclosed fact is a completed open-market sale by a 10% owner, with holdings after the transaction reported as 0 shares.

02

Market read

Traders may monitor for follow-on insider activity, but there is no accompanying fundamental or regulatory catalyst in the text.

03

What to watch

The filing does not state the reason for the sale, and the absence of a 10b5-1 plan does not by itself confirm bearish fundamentals without additional context or subsequent filings.

Relevance 6/10Novelty 5/10Timing: Filed 2026-07-23, covering sales executed 2026-07-21 to 2026-07-22.

Background

This is an SEC Form 4 insider transaction disclosure for Ethos Technologies Inc. (LIFE).

Company-level read

Ticker impact

$LIFENeutralMedium confidence
Context

GV 2019 GP, L.L.C., a 10% owner, sold 72,482 shares of Ethos Technologies (LIFE) in open-market trades totaling about $1.39M.

Expected impact

Likely limited, short-lived impact unless follow-on sales occur; watch for additional Form 4s.

Evidence & confidence

The filing is a primary-source Form 4 showing a completed sale and post-transaction holdings of 0 shares, but it provides no stated reason or new operating/regulatory catalyst.

Market effects

No sector read-through is provided; this is a company-specific insider transaction.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity management or diversification, especially since the article does not cite any negative company development.

Key entities

  • Ethos Technologies Inc.

    Subject of the Form 4 insider sale; ticker LIFE.

  • GV 2019 GP, L.L.C.

    Reporter and 10% owner who sold shares indirectly.

Related articles

$LIFEMed

Top SMid Cap Pick: Ethos Technologies Leads Citi’s Rankings

Citi analyst Ronald Josey named Ethos Technologies (LIFE) his top SMID-cap pick after the company’s Q2 results. Activated policies growth accelerated to 133% YoY, with 107,800 net activated policies. Revenue rose to $189.6M (+113% YoY). Ethos raised 2026 revenue guidance to $727M-$731M and adjusted EBITDA to $119M-$123M. Citi lifted its price target to $33 and kept Buy/High Risk.

$LIFEHigh

Ethos Technologies Inc. (LIFE): Results of Operations and Financial Condition

Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 life-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Ethos Reports Second Quarter Fiscal Year 2026 Financial Results • Q2 Revenue grew 113% year-over-year to $190 million • Q2 Direct Channel Revenue grew 131% year-over-year to $116 million • Q2 Third-Party Revenue grew 90% year